Erasca, Inc. (ERAS) vs MiniMed Group, Inc. Common Stock (MMED)

A side-by-side comparison of Erasca, Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Erasca, Inc. logo
ERAS
Erasca, Inc.
$4.94B
$14.24HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
MiniMed Group, Inc. Common Stock logo
MMED
MiniMed Group, Inc. Common Stock
$5.48B
$19.53HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT

Total return — ERAS vs MMED

growth of $100 · dividends reinvested · last 1y
ERAS -4.8% (-4.8%/yr)MMED +9.0% (+9.0%/yr)MMED compounded faster over this window
6080100120140Start $100$95$109
ERAS MMED

ERAS vs MMED: by the numbers

  • •MMED is the larger company ($5.48B vs $4.94B market cap).
  • •Both run net losses; ERAS's is the smaller (0.00% vs -10.21% net margin).

Metrics side by side

Valuation

MetricERASMMED
Forward P/EN/A29.00
P/S ratioN/A1.70
P/B ratio13.661.52
EV / EBITDAN/A30.49

Profitability

MetricERASMMED
Gross margin0.00%53.85%
Operating margin0.00%0.53%
Net margin0.00%-10.21%
ROE-79.37%-9.09%
ROIC-38.03%0.43%

Growth (annualized)

MetricERASMMED
Total return CAGR (5Y)-8.34%N/A

Go deeper

Full ERAS analysisFull MMED analysisInteractive comparison tool

Dig into the metrics

Erasca ROEMiniMed Group, Inc. Common Stock ROEErasca operating marginMiniMed Group, Inc. Common Stock operating marginErasca revenue growthMiniMed Group, Inc. Common Stock revenue growthErasca free cash flowMiniMed Group, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.